SCYNEXIS Secures $62,000,000 New Round

  • Feed Type
  • Date
    5/2/2014
  • Company Name
    SCYNEXIS
  • Mailing Address
    3501 C Tricenter Boulevard Durham, NC 27713 USA
  • Company Description
    SCYNEXIS, Inc. (NASDAQ: SCYX) is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery of innovative medicines over a broad range of therapy areas.
  • Website
    http://www.scynexis.com
  • Transaction Type
    IPO
  • Transaction Amount
    $62,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy